As of 2026-04-24, the Relative Valuation of Bioatla Inc (BCAB) is (458.90) USD. This relative valuation is based on P/E multiples. With the latest stock price at 5.84 USD, the upside of Bioatla Inc based on Relative Valuation is -7957.8%.
The range of the Relative Valuation is (421.90) - (491.79) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 19.0x - 25.0x | 21.8x |
| Forward P/E multiples | 19.6x - 22.8x | 20.8x |
| Fair Price | (421.90) - (491.79) | (458.90) |
| Upside | -7324.4% - -8521.1% | -7957.8% |
| Date | P/E |
| 2026-04-17 | -0.21 |
| 2026-04-16 | -0.23 |
| 2026-04-15 | -0.21 |
| 2026-04-14 | -0.20 |
| 2026-04-13 | -0.20 |
| 2026-04-10 | -0.21 |
| 2026-04-09 | -0.21 |
| 2026-04-08 | -0.21 |
| 2026-04-07 | -0.22 |
| 2026-04-06 | -0.26 |
| 2026-04-02 | -0.30 |
| 2026-04-01 | -0.31 |
| 2026-03-31 | -0.37 |
| 2026-03-30 | -0.36 |
| 2026-03-27 | -0.36 |
| 2026-03-26 | -0.39 |
| 2026-03-25 | -0.37 |
| 2026-03-24 | -0.34 |
| 2026-03-23 | -0.39 |
| 2026-03-20 | -0.39 |
| 2026-03-19 | -0.36 |
| 2026-03-18 | -0.37 |
| 2026-03-17 | -0.41 |
| 2026-03-16 | -0.42 |
| 2026-03-13 | -0.38 |
| 2026-03-12 | -0.39 |
| 2026-03-11 | -0.39 |
| 2026-03-10 | -0.40 |
| 2026-03-09 | -0.44 |
| 2026-03-06 | -0.39 |
| 2026-03-05 | -0.39 |
| 2026-03-04 | -0.40 |
| 2026-03-03 | -0.43 |
| 2026-03-02 | -0.47 |
| 2026-02-27 | -0.57 |
| 2026-02-26 | -0.55 |
| 2026-02-25 | -0.44 |
| 2026-02-24 | -0.45 |
| 2026-02-23 | -0.44 |
| 2026-02-20 | -0.39 |
| 2026-02-19 | -0.38 |
| 2026-02-18 | -0.33 |
| 2026-02-17 | -0.33 |
| 2026-02-13 | -0.35 |
| 2026-02-12 | -0.38 |
| 2026-02-11 | -0.43 |
| 2026-02-10 | -0.47 |
| 2026-02-09 | -0.44 |
| 2026-02-06 | -0.49 |
| 2026-02-05 | -0.44 |